Steatohepatitis
Epidemiology:
Common sites:
Gross features:
Histologic features:
- early
stage – changes localized to acinar zone 3
- liver-cell
ballooning
- intracytoplasmic Mallory bodies
- irregular,
densely eosinophilic strands or clumps
- ubiquitin immunostaining
- inflammatory
infiltrates
- perivenular and pericellular “chicken-wire” fibrosis
- grading
system (Brunt):
- grade
1 (mild):
- steatosis (mainly macrovesicular) involving up to 66% of lobules
- occasional
ballooned perivenular hepatocytes
- scattered
neutrophils + / - neutrophils
- none
or mild chronic portal inflammation
- grade
2 (moderate):
- steatosis of any degree
- obvious
ballooning (mainly perivenular)
- intralobular neutrophils
- perivenular pericellular
fibrosis maybe
- mild
to moderate portal and intralobular chronic
inflammation
- grade
3 (severe)
- panlobular steatosis
- obvious
perivenular ballooning and disarray
- marked
lobular inflammation
- neutrophils may be concentrated in
perivenular areas of ballooning and in areas
of pericellular fibrosis if evident
- portal
inflammation mild or moderate
- Fibrosis
staging (Brunt):
§
Stage 1:
·
Pericellular fibrosis in perivenular areas, focal or extensive
§
Stage 2:
·
As above, plus focal or extensive periportal
fibrosis
§
Stage 3:
·
Bridging fibrosis, focal or extensive
§
Stage 4:
·
Cirrhosis
Immunophenotype:
Marker:
|
Sensitivity:
|
Specificity:
|
|
|
|
Molecular features:
Other features:
- alchohol is most common cause
- EM –
filamentous structure
- Factors
that may contribute to whether or not a patient will develop alcoholic liver
disease:
- Women
more susceptible (decreased gastric metabolism, decreased body mass)
- Genetic
susceptibility (unknown?)
- Polymorphisms
in detoxifying enzymes
- Causes
of death from alcoholic cirrhosis:
- Variceal bleed
- Hepatic
coma
- Infection
- Hepatorenal syndrome
- Hepatocellular carcinoma (3-6%)
References:
o
Brunt EM, Janney CG, Di Bisceglie AM, et al.
Nonalcoholic steatohepatitis: a proposal for
grading and staging the histological lesions.
Am J Gastroenterol
1999;94:2467-2474.